Hormonal function of the fetoplacental complex in women with gestational diabetes
DOI:
https://doi.org/10.15574/PP.2024.98.42Keywords:
gestational diabetes, preeclampsia, fetoplacental complex, pregnant womenAbstract
Gestational diabetes is a common disease among pregnant women. The fetoplacental complex plays a key role in fetal development and pregnancy maintenance. Research on placental hormonal function in women with gestational diabetes is important to improve pregnancy outcomes and maternal and child health.
Aim - to analyze the hormonal function of the fetoplacental complex in women with gestational diabetes for improving monitoring and treatment algorithms of this condition to improve pregnancy outcome and improving mother’s and child’s health.
Materials and methods. The main clinical, laboratory and functional studies were carried out at the following facilities: Kyiv City Maternity Hospital No. 5 and SI "Institute of Pediatrics, Obstetrics and Gynecology of the National Academy of Medical Sciences of Ukraine". 120 pregnant women were studied: 90 women with gestational diabetes (main group) and 30 women without placental dysfunction (control group). The average age of patients in the main group was 30.8±0.6 years, the control group was 30.4±0.5 years. The diagnosis of gestational diabetes was confirmed by laboratory and instrumental methods in accordance with FIGO recommendations. The functional activity of the fetoplacental complex was assessed by the level of placental lactogen, estriol and progesterone in the blood of women at 26-32 and 37-39 weeks of pregnancy. Statistical processing of the results was carried out using methods of variational and alternative statistics with using a computer program package.
Results. The level of placental lactogen in gestational diabetes in the 26-32 week exceeds the level of healthy pregnant women by 10-16%. In patients with gestational diabetes, the concentration of progesterone in the 26-32 week is also lower than in healthy women, and after 36 weeks it is reduced by half. A decrease in progesterone of less than 25 percentile (pc) is associated with the threat of premature birth, and below 15 pc is characteristic of a violation of the condition of the fetus. Estriol levels in pregnant women with gestational diabetes decrease to 35.5 pc by the last weeks of pregnancy. In pregnant women with gestational diabetes and preeclampsia, a decrease in the level of placental lactogen and a moderate decrease in the content of estriol was noted, which indicates adverse changes in the mother-placenta-fetus system.
Conclusions. Analysis of hormonal function in patients with gestational diabetes revealіs changes in estriol, placental lactogen, and progesterone associated with pregnancy complications. These data emphasize the importance of regular monitoring to prevent or treat complications.
The research was carried out in accordance with the principles of the Helsinki Declartion. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Alexopoulos AS, Blair R, Peters AL. (2019). Management of Preexisting Diabetes in Pregnancy: A Review. JAMA. 321(18): 1811-1819. https://doi.org/10.1001/jama.2019.4981; PMid:31087027 PMCid:PMC6657017
American Diabetes Association Professional Practice Committee. (2022). Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes care. 45; Suppl 1: S17-S38. https://doi.org/10.2337/dc22-S002; PMid:34964875
Bahri Khomami M, Joham AE, Boyle JA, Piltonen T, Silagy M, Arora C et al. (2019). Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity-A systematic review, meta-analysis, and meta-regression. Obesity reviews: an official journal of the International Association for the Study of Obesity. 20(5): 659-674. https://doi.org/10.1111/obr.12829; PMid:30674081
Banker M, Puttabyatappa M, O'Day P, Goodrich JM, Kelley AS, Domino SE et al. (2021). Association of Maternal-Neonatal Steroids With Early Pregnancy Endocrine Disrupting Chemicals and Pregnancy Outcomes. The Journal of clinical endocrinology and metabolism. 106(3): 665-687. https://doi.org/10.1210/clinem/dgaa909; PMid:33280001 PMCid:PMC7947779
Chatuphonprasert W, Jarukamjorn K, Ellinger I. (2018). Physiology and pathophysiology of steroid biosynthesis, transport and metabolism in the human placenta. Front Pharmacol. 9(1027). https://doi.org/10.3389/fphar.2018.01027; PMid:30258364 PMCid:PMC6144938
Daskalakis G, Marinopoulos S, Krielesi V, Papapanagiotou A, Papantoniou N et al. (2008). Placental pathology in women with gestational diabetes. Acta obstetricia et gynecologica Scandinavica. 87(4): 403-407. https://doi.org/10.1080/00016340801908783; PMid:18382864
Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC et al. (2015). The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 131; Suppl 3: S173-S211. https://doi.org/10.1016/S0020-7292(15)30033-3
Hufnagel A, Dearden L, Fernandez-Twinn DS, Ozanne SE. (2022). Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia. The Journal of endocrinology. 253(2): R47-R63. https://doi.org/10.1530/JOE-21-0332; PMid:35258482 PMCid:PMC9066586
Lenke L, Martínez de la Escalera G, Clapp C, Bertsch T, Triebel J. (2020). A Dysregulation of the Prolactin/Vasoinhibin Axis Appears to Contribute to Preeclampsia. Front Endocrinol (Lausanne). 10: 893. https://doi.org/10.3389/fendo.2019.00893; PMid:31998232 PMCid:PMC6962103
Männik J, Vaas P, Rull K, Teesalu P, Rebane T, Laan M. (2010). Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. The Journal of clinical endocrinology and metabolism. 95(5): 2433-2442. https://doi.org/10.1210/jc.2010-0023; PMid:20233782 PMCid:PMC2869554
Markl-Hahn H, Neugebauer L, Lenke L, Ecker S, Merz T, McCook O et al. (2022). Human Placental Tissue Contains A Placental Lactogen-Derived Vasoinhibin. J Endocr Soc. 6(4): bvac029. https://doi.org/10.1210/jendso/bvac029; PMid:35265784 PMCid:PMC8900287
Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, Bandurska-Stankiewicz EM. (2022). Gestational Diabetes Mellitus-Recent Literature Review. Journal of clinical medicine. 11(19): 5736. https://doi.org/10.3390/jcm11195736; PMid:36233604 PMCid:PMC9572242
Neven ACH, Mousa A, Boyle JA, Teede HJ. (2023). Endocrine and metabolic interactions in healthy pregnancies and hyperinsulinemic pregnancies affected by polycystic ovary syndrome, diabetes and obesity. Front Endocrinol (Lausanne). 13: 993619. https://doi.org/10.3389/fendo.2022.993619; PMid:36733795 PMCid:PMC9886898
Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. (2018). The Pathophysiology of Gestational Diabetes Mellitus. International journal of molecular sciences. 19(11): 3342. https://doi.org/10.3390/ijms19113342; PMid:30373146 PMCid:PMC6274679
Qiao L, Saget S, Lu C, Hay WW Jr, Karsenty G, Shao J. (2021). Adiponectin Promotes Maternal β-Cell Expansion Through Placental Lactogen Expression. Diabetes. 70(1): 132-142. https://doi.org/10.2337/db20-0471; PMid:33087456 PMCid:PMC7881845
Rassie K, Giri R, Joham AE, Teede H, Mousa A. (2022). Human Placental Lactogen in Relation to Maternal Metabolic Health and Fetal Outcomes: A Systematic Review and Meta-Analysis. Int J Mol Sci. 23(24): 15621. https://doi.org/10.3390/ijms232415621; PMid:36555258 PMCid:PMC9779646
Sibiak R, Jankowski M, Gutaj P, Mozdziak P, Kempisty B, Wender-Ożegowska E. (2020). Placental Lactogen as a Marker of Maternal Obesity, Diabetes, and Fetal Growth Abnormalities: Current Knowledge and Clinical Perspectives. J Clin Med. 9(4): 1142. https://doi.org/10.3390/jcm9041142; PMid:32316284 PMCid:PMC7230810
Wan J, Hu Z, Zeng K, Yin Y, Zhao M et al. (2018). The reduction in circulating levels of estrogen and progesterone in women with preeclampsia. Pregnancy hypertension. 11: 18-25. https://doi.org/10.1016/j.preghy.2017.12.003; PMid:29523268
Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L et al. (2022). IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria. Diabetes research and clinical practice. 183: 109050. https://doi.org/10.1016/j.diabres.2021.109050; PMid:34883186
Yanachkova V, Staynova R, Stankova T, Kamenov Z. (2023). Placental Growth Factor and Pregnancy-Associated Plasma Protein-A as Potential Early Predictors of Gestational Diabetes Mellitus. Medicina (Kaunas). 59(2): 398. https://doi.org/10.3390/medicina59020398; PMid:36837599 PMCid:PMC9961527
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ukrainian Journal of Perinatology and Pediatrics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
